Huntington residents and visitors now won’t have to travel far to satisfy their McDonald’s cravings as the fast food chain is setting up shop in the small city. Visit this article to learn more: KETK ...

A team from the University of North Texas Health Science Center at Fort Worth has conducted the largest characterization of ...

It was a busy week in the biotech sector with lots of data readouts. This apart, the key regulatory updates and pipeline news also continued to be in the spotlight.

UniQure stock doubled Tuesday after the company reached a testing agreement with the FDA for its Huntington's disease ...

Qure's AMT-130 shows promising results for Huntington’s disease. Learn why QURE stock faces commercialization challenges ...

William Blair analyst Sami Corwin has maintained their bullish stance on QURE stock, giving a Buy rating today.Pick the best stocks and ...

The FDA will allow uniQure NV to seek accelerated approval for its Huntington’s disease gene therapy more than doubled the ...

The company now says that, during a recent meeting with the FDA, the two parties agreed on some key elements for an ...

Raymond James and Cantor both released bullish notes on uniQure (QURE) Tuesday following an update on the company's ...

UniQure shares more than doubled after the company reached agreement with the Food and Drug Administration on key elements of an accelerated approval pathway for AMT-130, a potential treatment for ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

U.S. Food and Drug Administration (FDA) agrees that data from ongoing Phase I/II studies compared to a natural history external control may ...